🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

CVS Health Corporation

CVS Healthcare
$101.96 +$1.48 (1.47%)
Market Cap: $130.09 B
Gurus Holding
22
Popularity Rank
#23
% of Shares Held
3.58%
Net Activity (Q1 2026)
-$384.37 M

Guru Ownership Trend

Guru Analysis for CVS Health Corporation (CVS)

CVS Health Corporation (CVS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 22 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.66 B.

Top institutional holders include Richard Pzena and Chris Davis.

Notably, Larry Robbins has expressed high conviction in this stock, allocating 14.78% of their equity portfolio to it.

Institutional sentiment is currently Bearish. This is evidenced by a $384.37 M net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 305.8%. Conversely, Jefferies Group reduced exposure by 59.7%.

Key Holders

Top 5 by Value

$989.18 M
$879.05 M
$588.69 M
$200.72 M
$194.78 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$56.99 M
Total Buy Value
New Buys 2
Additions 2
-$441.36 M
Total Sell Value
Reductions 15
Sold Out 2

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
17
Net Buyers
4

FAQs for CVS Health Corporation (CVS)

Major holders include Richard Pzena ($989.18 M), Chris Davis ($879.05 M), Larry Robbins ($588.69 M). According to the latest reported data, 22 tracked investment managers collectively hold approximately 45.69 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $384.37 M, with 4 managers increasing positions and 17 managers reducing holdings.

During the most recent reporting period, 15 managers trimmed their positions, while 2 fully exited CVS. The total reported sell value was $441.36 M.

Yes, 2 managers opened new positions in CVS, and 2 increased their existing holdings. The total reported buy value was $56.99 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
3.21% Reduce -11.6% 13,773,053 $989.18 M Q1 2026
4.04% Reduce -4.1% 12,239,666 $879.05 M Q1 2026
14.78% 8,196,799 $588.69 M Q1 2026
0.62% Reduce -3.4% 2,794,787 $200.72 M Q1 2026
10.03% 2,712,000 $194.78 M Q1 2026
0.08% Reduce -8.7% 2,387,964 $169.64 M Q1 2026
0.56% Reduce -14.9% 702,151 $50.43 M Q1 2026
0.09% Add 305.8% 681,806 $48.97 M Q1 2026
0.12% Reduce -12.0% 634,846 $45.59 M Q1 2026
0.20% Reduce -40.4% 618,428 $44.42 M Q1 2026
0.03% New Buy 263,153 $18.9 M Q1 2026
0.04% Reduce -34.5% 196,104 $14.08 M Q1 2026
1.03% Reduce -0.5% 100,195 $7.2 M Q1 2026
0.07% Reduce -17.3% 93,220 $6.7 M Q1 2026
0.00% Reduce -4.3% 88,392 $6.35 M Q1 2026
3.36% Reduce -5.9% 67,462 $4.85 M Q1 2026
0.78% Reduce -10.7% 50,000 $3.59 M Q1 2026
0.65% 42,000 $3.02 M Q1 2026
0.01% Reduce -59.7% 22,042 $1.58 M Q1 2026
0.11% Add 58.3% 19,132 $1.37 M Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form